Mandy L.Y. Sin
YOU?
Author Swipe
View article: Supplementary Methods from Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA
Supplementary Methods from Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA Open
Supplemental Methods
View article: Supplementary Methods from Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA
Supplementary Methods from Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA Open
Supplemental Methods
View article: Supplementary Data from Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA
Supplementary Data from Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA Open
Supplemental Figures
View article: Supplementary Data from Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA
Supplementary Data from Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA Open
Supplemental Tables
View article: Supplementary Data from Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA
Supplementary Data from Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA Open
Supplemental Figures
View article: Supplementary Data from Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA
Supplementary Data from Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA Open
Supplemental Tables
View article: Data from Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA
Data from Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA Open
Current regimens for the detection and surveillance of bladder cancer are invasive and have suboptimal sensitivity. Here, we present a novel high-throughput sequencing (HTS) method for detection of urine tumor DNA (utDNA) called utDNA CAPP…
View article: Data from Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA
Data from Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA Open
Current regimens for the detection and surveillance of bladder cancer are invasive and have suboptimal sensitivity. Here, we present a novel high-throughput sequencing (HTS) method for detection of urine tumor DNA (utDNA) called utDNA CAPP…
View article: Supplementary Table S1 from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics
Supplementary Table S1 from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics Open
Full list of differentially expressed genes identified in comparison of the 13 bladder cancer urine samples to 8 control urine samples based on urinary RNA-seq data in the urinary biomarker discovery.
View article: Supplementary Figure S1 from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics
Supplementary Figure S1 from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics Open
Gene expression of the candidate reference genes for model construction in 29 urine samples using qPCR. The Ct values of the 5 reference genes, the standard derivation and grand mean Ct values of all samples over all 5 genes were plotted.
View article: Supplementary Table S7 from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics
Supplementary Table S7 from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics Open
Table summarizing the univariate logistic analysis for predicting bladder cancer of 11 candidate genes (8 cancer and 3 reference genes) that were evaluated in the training cohort (n=102).
View article: Supplementary Figure S1 from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics
Supplementary Figure S1 from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics Open
Gene expression of the candidate reference genes for model construction in 29 urine samples using qPCR. The Ct values of the 5 reference genes, the standard derivation and grand mean Ct values of all samples over all 5 genes were plotted.
View article: Data from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics
Data from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics Open
Purpose: The majority of bladder cancer patients present with localized disease and are managed by transurethral resection. However, the high rate of recurrence necessitates lifetime cystoscopic surveillance. Developing a sensitive and spe…
View article: Supplementary Table S3 from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics
Supplementary Table S3 from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics Open
Full list of differentially expressed genes identified in comparison of the 3 LG bladder cancer urine samples to 8 control urine samples based on urinary RNA-seq data in the urinary biomarker discovery.
View article: Supplementary Table S6 from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics
Supplementary Table S6 from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics Open
List of uniformly expressed genes in all 23 RNA-seq samples selected for qPCR validation in urine samples as reference markers.
View article: Supplementary Table S5 from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics
Supplementary Table S5 from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics Open
Table summarizing the 16 significant biomarkers selected for qPCR validation in urine samples, which were overexpressed in cancer samples compared to control samples based on the standard differential analysis of the RNA-seq data and under…
View article: Data from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics
Data from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics Open
Purpose: The majority of bladder cancer patients present with localized disease and are managed by transurethral resection. However, the high rate of recurrence necessitates lifetime cystoscopic surveillance. Developing a sensitive and spe…
View article: Supplementary Table S7 from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics
Supplementary Table S7 from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics Open
Table summarizing the univariate logistic analysis for predicting bladder cancer of 11 candidate genes (8 cancer and 3 reference genes) that were evaluated in the training cohort (n=102).
View article: Supplementary Table S2 from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics
Supplementary Table S2 from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics Open
Full list of differentially expressed genes identified in comparison of the 10 HG bladder cancer urine samples to 8 control urine samples based on urinary RNA-seq data in the urinary biomarker discovery.
View article: Supplementary Table S6 from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics
Supplementary Table S6 from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics Open
List of uniformly expressed genes in all 23 RNA-seq samples selected for qPCR validation in urine samples as reference markers.
View article: Supplementary Table S5 from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics
Supplementary Table S5 from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics Open
Table summarizing the 16 significant biomarkers selected for qPCR validation in urine samples, which were overexpressed in cancer samples compared to control samples based on the standard differential analysis of the RNA-seq data and under…
View article: Supplementary Table S4 from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics
Supplementary Table S4 from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics Open
Full list of differentially expressed genes identified in comparison of the 10 HG bladder cancer urine samples to 3 LG bladder cancer urine samples based on urinary RNA-seq data in the urinary biomarker discovery.
View article: Supplementary Table S1 from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics
Supplementary Table S1 from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics Open
Full list of differentially expressed genes identified in comparison of the 13 bladder cancer urine samples to 8 control urine samples based on urinary RNA-seq data in the urinary biomarker discovery.
View article: Supplementary Table S2 from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics
Supplementary Table S2 from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics Open
Full list of differentially expressed genes identified in comparison of the 10 HG bladder cancer urine samples to 8 control urine samples based on urinary RNA-seq data in the urinary biomarker discovery.
View article: Supplementary Table S3 from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics
Supplementary Table S3 from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics Open
Full list of differentially expressed genes identified in comparison of the 3 LG bladder cancer urine samples to 8 control urine samples based on urinary RNA-seq data in the urinary biomarker discovery.
View article: Supplementary Table S4 from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics
Supplementary Table S4 from Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics Open
Full list of differentially expressed genes identified in comparison of the 10 HG bladder cancer urine samples to 3 LG bladder cancer urine samples based on urinary RNA-seq data in the urinary biomarker discovery.
View article: Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test
Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test Open
Nucleic acid amplification tests (NAATs) are the primary means of identifying acute infections caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Accurate and fast test results may permit more efficient use of protecti…
View article: MP24-05 USE OF A NOVEL mRNA BIOMARKER PANEL FOR BLADDER CANCER RISK STRATIFICATION
MP24-05 USE OF A NOVEL mRNA BIOMARKER PANEL FOR BLADDER CANCER RISK STRATIFICATION Open
You have accessJournal of UrologyBladder Cancer: Epidemiology & Evaluation I (MP24)1 Apr 2020MP24-05 USE OF A NOVEL mRNA BIOMARKER PANEL FOR BLADDER CANCER RISK STRATIFICATION Eugene Shkolyar*, Qian Zhao, Nicolas Teslovich, Mandy Sin, Dhar…
View article: Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA
Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA Open
Current regimens for the detection and surveillance of bladder cancer are invasive and have suboptimal sensitivity. Here, we present a novel high-throughput sequencing (HTS) method for detection of urine tumor DNA (utDNA) called utDNA CAPP…
View article: Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics
Deep Sequencing of Urinary RNAs for Bladder Cancer Molecular Diagnostics Open
Purpose: The majority of bladder cancer patients present with localized disease and are managed by transurethral resection. However, the high rate of recurrence necessitates lifetime cystoscopic surveillance. Developing a sensitive and spe…